CellaVision AB (publ) (CEVI.ST)
SEK 222.0
(2.07%)
SEK 222.0
(2.07%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 64.7 Million SEK | -36.87% |
| 2022 | 102.49 Million SEK | -25.0% |
| 2021 | 136.65 Million SEK | 2.92% |
| 2020 | 132.77 Million SEK | -23.56% |
| 2019 | 173.69 Million SEK | 3493.9% |
| 2018 | 4.83 Million SEK | 196.14% |
| 2017 | 1.63 Million SEK | -67.71% |
| 2016 | 5.05 Million SEK | 344.89% |
| 2015 | 1.13 Million SEK | 0.0% |
| 2014 | - SEK | -100.0% |
| 2013 | 19.97 Million SEK | 39.98% |
| 2012 | 14.27 Million SEK | -24.55% |
| 2011 | 18.91 Million SEK | -47.21% |
| 2010 | 35.83 Million SEK | 115.63% |
| 2009 | 16.61 Million SEK | -27.09% |
| 2008 | 22.79 Million SEK | 141.58% |
| 2007 | 9.43 Million SEK | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 44.97 Million SEK | -58.14% |
| 2024 Q3 | 35.38 Million SEK | -21.33% |
| 2024 Q1 | 107.44 Million SEK | 66.06% |
| 2023 Q4 | 64.7 Million SEK | -47.93% |
| 2023 Q1 | 134.83 Million SEK | 31.55% |
| 2023 Q2 | 133.05 Million SEK | -1.32% |
| 2023 FY | 64.7 Million SEK | -36.87% |
| 2023 Q3 | 124.26 Million SEK | -6.61% |
| 2022 Q2 | 167.73 Million SEK | -5.1% |
| 2022 Q4 | 102.49 Million SEK | -35.97% |
| 2022 FY | 102.49 Million SEK | -25.0% |
| 2022 Q1 | 176.74 Million SEK | 29.34% |
| 2022 Q3 | 160.07 Million SEK | -4.57% |
| 2021 Q4 | 136.65 Million SEK | -16.49% |
| 2021 Q1 | 168.6 Million SEK | 26.99% |
| 2021 FY | 136.65 Million SEK | 2.92% |
| 2021 Q2 | 131.64 Million SEK | -21.92% |
| 2021 Q3 | 163.63 Million SEK | 24.29% |
| 2020 Q2 | 155.97 Million SEK | -9.34% |
| 2020 Q1 | 172.03 Million SEK | -0.96% |
| 2020 FY | 132.77 Million SEK | -23.56% |
| 2020 Q4 | 132.77 Million SEK | -9.17% |
| 2020 Q3 | 146.18 Million SEK | -6.28% |
| 2019 Q1 | 71.47 Million SEK | 1378.96% |
| 2019 Q2 | 73.56 Million SEK | 2.91% |
| 2019 Q4 | 173.69 Million SEK | 126.9% |
| 2019 Q3 | 76.54 Million SEK | 4.06% |
| 2019 FY | 173.69 Million SEK | 3493.9% |
| 2018 Q1 | 30.82 Million SEK | 1788.54% |
| 2018 Q4 | 4.83 Million SEK | -87.47% |
| 2018 FY | 4.83 Million SEK | 196.14% |
| 2018 Q3 | 38.56 Million SEK | -0.41% |
| 2018 Q2 | 38.72 Million SEK | 25.65% |
| 2017 FY | 1.63 Million SEK | -67.71% |
| 2017 Q4 | 1.63 Million SEK | -95.44% |
| 2017 Q2 | 28.83 Million SEK | -1.48% |
| 2017 Q1 | 29.26 Million SEK | 479.09% |
| 2017 Q3 | 35.79 Million SEK | 24.13% |
| 2016 Q1 | 24.03 Million SEK | 2016.02% |
| 2016 Q3 | 30.85 Million SEK | 14.49% |
| 2016 Q4 | 5.05 Million SEK | -83.62% |
| 2016 Q2 | 26.95 Million SEK | 12.13% |
| 2016 FY | 5.05 Million SEK | 344.89% |
| 2015 Q2 | 25.27 Million SEK | -27.49% |
| 2015 Q4 | 1.13 Million SEK | -95.54% |
| 2015 FY | 1.13 Million SEK | 0.0% |
| 2015 Q1 | 34.86 Million SEK | 621.95% |
| 2015 Q3 | 25.49 Million SEK | 0.87% |
| 2014 Q3 | 25.35 Million SEK | 3.94% |
| 2014 Q4 | 4.82 Million SEK | -80.95% |
| 2014 Q1 | 31.22 Million SEK | 56.31% |
| 2014 FY | - SEK | -100.0% |
| 2014 Q2 | 24.39 Million SEK | -21.89% |
| 2013 FY | 19.97 Million SEK | 39.98% |
| 2013 Q1 | 39.33 Million SEK | 175.58% |
| 2013 Q3 | 33.05 Million SEK | -8.95% |
| 2013 Q4 | 19.97 Million SEK | -39.57% |
| 2013 Q2 | 36.3 Million SEK | -7.69% |
| 2012 Q4 | 14.27 Million SEK | -57.34% |
| 2012 Q2 | 24.98 Million SEK | 2.58% |
| 2012 Q1 | 24.35 Million SEK | 28.75% |
| 2012 FY | 14.27 Million SEK | -24.55% |
| 2012 Q3 | 33.45 Million SEK | 33.92% |
| 2011 FY | 18.91 Million SEK | -47.21% |
| 2011 Q4 | 18.91 Million SEK | -25.46% |
| 2011 Q3 | 25.37 Million SEK | -23.69% |
| 2011 Q1 | 27.81 Million SEK | -22.37% |
| 2011 Q2 | 33.25 Million SEK | 19.55% |
| 2010 Q1 | 16.91 Million SEK | 1.8% |
| 2010 Q2 | 22.96 Million SEK | 35.78% |
| 2010 FY | 35.83 Million SEK | 115.63% |
| 2010 Q3 | 30.07 Million SEK | 30.94% |
| 2010 Q4 | 35.83 Million SEK | 19.15% |
| 2009 Q3 | 25.37 Million SEK | 28.94% |
| 2009 FY | 16.61 Million SEK | -27.09% |
| 2009 Q2 | 19.68 Million SEK | 0.0% |
| 2009 Q4 | 16.61 Million SEK | -34.52% |
| 2008 FY | 22.79 Million SEK | 141.58% |
| 2008 Q4 | 22.79 Million SEK | 0.0% |
| 2007 FY | 9.43 Million SEK | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Acarix AB (publ) | - SEK | -Infinity% |
| ADDvise Group AB (publ) | 1.61 Billion SEK | 95.99% |
| ADDvise Group AB (publ) | 1.61 Billion SEK | 95.99% |
| Arcoma AB | 3.87 Million SEK | -1570.617% |
| Bactiguard Holding AB (publ) | 233.09 Million SEK | 72.242% |
| BICO Group AB (publ) | 1.85 Billion SEK | 96.508% |
| Boule Diagnostics AB (publ) | 166.1 Million SEK | 61.046% |
| Clinical Laserthermia Systems AB (publ) | 454 Thousand SEK | -14151.762% |
| Chordate Medical Holding AB (publ) | - SEK | -Infinity% |
| C-Rad AB (publ) | 1.8 Million SEK | -3494.611% |
| Duearity AB (publ) | 10.58 Million SEK | -511.444% |
| Dignitana AB (publ) | 19.1 Million SEK | -238.688% |
| Episurf Medical AB (publ) | 5.2 Million SEK | -1144.288% |
| Getinge AB (publ) | 8.07 Billion SEK | 99.199% |
| Scandinavian Real Heart AB (Publ) | 8.24 Million SEK | -684.314% |
| Iconovo AB (publ) | 7.72 Million SEK | -737.589% |
| Integrum AB (publ) | 6.42 Million SEK | -907.179% |
| Luxbright AB (publ) | 206.02 Thousand SEK | -31305.564% |
| Mentice AB (publ) | 9.55 Million SEK | -577.022% |
| OssDsign AB (publ) | 3.15 Million SEK | -1954.063% |
| Paxman AB (publ) | 13.57 Million SEK | -376.809% |
| Promimic AB (publ) | - SEK | -Infinity% |
| Qlife Holding AB (publ) | 20.73 Million SEK | -212.107% |
| SciBase Holding AB (publ) | 6.79 Million SEK | -851.935% |
| ScandiDos AB (publ) | - SEK | -Infinity% |
| Sectra AB (publ) | 31.78 Million SEK | -103.545% |
| Sedana Medical AB (publ) | 4.3 Million SEK | -1402.624% |
| Senzime AB (publ) | 11.46 Million SEK | -464.205% |
| SpectraCure AB (publ) | 6.71 Million SEK | -863.272% |
| Stille AB | 62.94 Million SEK | -2.798% |
| Vitrolife AB (publ) | 2.08 Billion SEK | 96.903% |
| Xvivo Perfusion AB (publ) | 31.43 Million SEK | -105.818% |